Healthcare communications continues to evolve and comprises a number of diverse, yet intrinsically linked disciplines, including medical education, PR, policy, public affairs and market access. More: Communications Team of the Year open for entry Source: News
read moreA year after NewLink Genetics reported a phase 3 trial failure for its pancreatic cancer vaccine that crushed shares, a shareholder is taking it to the company’s current and former execs for “gross mismanagement” and other allegations. More: Shareholder suit
read moreIt’s good to be Merck these days. Less than a week after its immuno-oncology med Keytruda nabbed an FDA go-ahead in bladder cancer, the company scored a speedy review for the therapy in stomach cancer. More: Fresh off two new
read moreIndia’s Granules bought a U.S. R&D facility in 2014 and is now ready to add manufacturing as part of plans to expand significantly in the U.S. market. More: India's Granules is adding manufacturing and 102 jobs to its U.S. site
read moreAlexion, picking up the pieces after a sales scandal, pushed its C-suite makeover into second gear. Four members of the company’s top brass are set to move on, the company said Tuesday, and meanwhile, new skipper Ludwig Hantson has made
read moreGP leaders are warning that nearly 3.5 million patients are at risk of losing their family doctor, if the status of doctors from the European Union is not protected during Brexit negotiations. More: NHS could lose more than 2,000 GPs
read more© 1994 - 2026 B.M. Pharmaceuticals